1. Recovery of Third, Fourth, and Sixth Cranial Nerve Palsies in Pituitary Adenoma and Meningioma Patients.
- Author
-
Lu LJ, Pelsma ICM, de Vries F, van Hulst-Ginjaar SPA, van Furth WR, Verstegen MJT, Fisher FL, Zamanipoor Najafadabadi AH, Biermasz NR, van der Meeren SW, and Notting IC
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Aged, Adult, Trochlear Nerve Diseases diagnosis, Trochlear Nerve Diseases etiology, Trochlear Nerve Diseases physiopathology, Follow-Up Studies, Meningioma complications, Meningioma diagnosis, Recovery of Function physiology, Pituitary Neoplasms complications, Pituitary Neoplasms diagnosis, Abducens Nerve Diseases etiology, Abducens Nerve Diseases diagnosis, Meningeal Neoplasms complications, Meningeal Neoplasms diagnosis, Adenoma complications, Adenoma diagnosis, Oculomotor Nerve Diseases etiology, Oculomotor Nerve Diseases diagnosis, Oculomotor Nerve Diseases physiopathology
- Abstract
Background: This retrospective, observational cohort study aimed to determine recovery rate and recovery time of ocular motor nerve palsies (OMP) of third (CN III), fourth (CN IV), or sixth cranial nerves (CN VI)-and associated prognostic factors-in meningioma and pituitary adenoma (PA) patients., Methods: A total of 25 meningioma (28 eyes) and 33 PA patients (36 eyes), treated at the Leiden University Medical Center in the Netherlands from January 1, 1978 to January 31, 2021, were included. OMPs were evaluated according to a newly created recovery scale using on-clinical and orthoptic examinations, which were performed every 3-4 months until palsy recovery, or at 18 months follow-up., Results: Recovery rates of CN III (meningioma 23.5% vs PA 92.3%), CN IV (meningioma 20% vs PA 100%), and CN VI (meningioma 60% vs PA 100%) palsies were observed at 18 months follow-up, with differences between the 2 tumor types being observed in the treated patients only. Median recovery time of all OMPs combined was significantly longer in meningioma patients (37.9 ± 14.3 months vs 3.3 ± 0.1 months; P < 0.001). No significant protective or risk factors for recovery rate or time were identified., Conclusions: OMP recovery rates in treated patients were more favorable in patients with PA compared with patients with meningiomas, independent of OMP cause. With these new insights in OMP recovery, more accurate prognoses and appropriate follow-up strategies can be determined for meningioma and PA patients with OMPs., Competing Interests: The authors report no conflicts of interest., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the North American Neuro-Ophthalmology Society.)
- Published
- 2024
- Full Text
- View/download PDF